Insiders · MLAB

Mark Christopher Capone

Director at Mesa Laboratories Inc /co/ (MLAB) since January 2024

Mark Christopher Capone has filed 12 insider reports with the SEC since July 2022, as director at Mesa Laboratories Inc /co/ (MLAB), director at Sera Prognostics, Inc. (SERA) and director at DermTech, Inc. (DMTK). In the last 12 months Mark Christopher Capone bought $99.3K of stock on the open market. The latest filing, on September 11, 2026, reports grant or award at Mesa Laboratories Inc /co/ (MLAB).

Filings
12
Companies
3
Bought on market
$99.3K
Sold on market
None

Companies where Mark Christopher Capone is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Mesa Laboratories Inc /co/ logo
MLAB
Mesa Laboratories Inc /co/
Directorsince January 20246,213$99.3K$76.35$127.93+68%Sep 11, 2026
Sera Prognostics, Inc. logo
SERA
Sera Prognostics, Inc.
Directorsince July 202644,379$1.81Jul 14, 2026
DermTech, Inc. logo
DMTK
DermTech, Inc.
Directorsince July 202282,054Jun 5, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Mark Christopher Capone with

Other insiders at the same companies

Questions about Mark Christopher Capone

What is Mark Christopher Capone's role at Mesa Laboratories Inc /co/?
Mark Christopher Capone reports to the SEC as director at Mesa Laboratories Inc /co/ (MLAB), according to the latest filing on September 11, 2026. Mark Christopher Capone has also filed as director at Sera Prognostics, Inc. (SERA) and director at DermTech, Inc. (DMTK).
How many shares does Mark Christopher Capone own?
After the latest filing that states it, Mark Christopher Capone directly owned 6,213 shares of Mesa Laboratories Inc /co/ (MLAB), 44,379 shares of Sera Prognostics, Inc. (SERA) and 82,054 shares of DermTech, Inc. (DMTK). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Mark Christopher Capone bought or sold stock recently?
The most recent open-market purchase was on March 10, 2026: bought 1,301 shares of Mesa Laboratories Inc /co/ (MLAB) for $99.3K at an average of $76.35.
How do I get alerts when Mark Christopher Capone files?
Follow Mark Christopher Capone on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Mark Christopher Capone filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Mark Christopher Capone (SEC CIK 0001352413). Totals count each trade once, skipping amendments whose original is on file, from Jul 21, 2022 on. View on SEC EDGAR · Get this as JSON